Riley Ennis

Riley Ennis is founder of biotech startup Immudicon and was recently selected as a Thiel Fellow in 2013. The company was founded based on three years of research on a cancer vaccine technology that teaches the immune cells of the body to recognize and remove tumors. He has been recognized by CNN, Google X, ABC, the American Society of Microbiology, Verizon Powerful Answers, Fox News, the GE Focus Forward Competition, the Intel International Science Fair, and the National Young Inventors Gallery. Before starting the Thiel Fellowship in 2013, Riley was a Junior at Dartmouth College, pursuing a double major in economics and biology, where he worked at the Dartmouth Hitchcock-Medical Center on cancer nanotechnology research projects as a Dartmouth Science Scholar.